This forum is for questions about medical issues and research aspects of
Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new
Hepatitis Social/Living with Hepatitis forum
All the best,
-- Jim
About a week after stopping I remember listening to music again and actually turning up the VOLUME!
My family went to a hockey game and I didn't mind all the people and noise. Food tasted good again. I started gaining weight.
It was like winter was over!
Enjoy not taking meds!
Like Mike, I know how good ending tx feels, both physically and mentally. Keep us posted, and particularily with any future trial information to which you may be privy.
Thanks for the kind words on the 24 week issue, Jim. There have been some vocal naysayers here insisting the additional 48 weeks of SOC is the only sure way to SVR. Like you, I'm quietly confident that SVR will be demonstrated after 24 weeks of VX + SOC combo therapy. Nobody really knows until the data are in, so now its just wait and see. We will know more as more posters here move into the follow-up phase.
All the best,
-- Jim
"If I had advanced stage 3 or stage 4 liver damage...."
-- Jim
-- Jim
I hope this finds you well and as fully clarified as possible, but if you need anything further clarified -- except maybe Ghee (clarified butter) please let me know as this is a slow Monday for me.
-- Jim
I'm assuming you're referring to my previous comments to you in an earlier post regarding duration of treatment? If so, I didn't "insist" an "additional 48 weeks of SOC is the only sure way to SVR." To recap in summary, what I said was:
(1) If I were 50-something, had advanced fibrosis (i.e. F3) and a high starting VL, then I'd be apprehensive about stopping at 24 weeks. I'd be worried about it and would at least express some concern over the situation, although not necessarily extend treatment to 48 weeks.
(2) For the reasons specified in #1 above, I would be worried. And the reason I would be worried is because the consequences of failure/relapse could be very significant in a negative way, and perhaps even become life threatening in a relatively short period of time (with SOC being the only option for years to come). That's a fact, not an opinion.
(3) The SVR rate for a prospective patient taking 12 weeks (VX950+SOC) + 12 weeks (SOC) will not be 100% (probably far from it). It will be less than 100% no matter what. That's a fact, not an opinion.
(4) The SVR rate for a prospective patient taking 12 weeks (VX950+SOC) + 36 weeks (SOC) will not be 100%. It will be less than 100% no matter what. However, it will be greater than the 24 week group described in #3 above. That's a fact, not an opinion.
(5) The SVR rate for VX950 has not been established. There is no (disclosed) track record whatsoever that has been established for VX950 in regards to its ability to deliver or enhance the probability of an SVR (yet). Therefore, any guesses on the statistical likelihood of VX950 greatly enhancing existing (mediocre) type 1 SVR rates, especially in lieu of simultaneously halving the normally prescribed duration of treatment in conjunction with having a relatively high risk profile, is just that: pure guesswork. That's a fact, not an opinion.
So, when you combine #1-#5 above, then you have the basic premise for what I was saying to you on a previous post. Nothing more, nothing less. And certainly not what you've simplistically mischaracterized in quotations above.
In the meantime, best of luck with your ongoing UND status. I'd guess your chances of SVR-ing are probably good (i.e. >50%); hopefully you'll reel one in. Take care...
----------------------------
I know it's probably not wise to step in between the two of you on this one but since we seem to get along pretty well, here goes...
Assuming the patient above, I can understand your analysis to a certain degree, but what's missing is that the patient (and doctor) had knowledge of all this information prior to entering the study which would randomly deal out 12, 24 or 48 weeks of treatment. I would therefore then think that the time to question extending beyond one's trial Arm would be prior to treating -- i.e. not enrolling in the trial if that might be a problem -- as opposed to at this juncture. Unless, of course, something happened during the trial -- such as a late response -- that wasn't anticipated and might suggest the shorter course would be too risky.
So, I guess what I'm saying is that either your hypothetical person above, should either play out the cards dealt by the trial or should not have entered the trial -- both being valid decisions IMO. Personally, I think this hypothetical person, given an RVR, stands a very good chance of SVR without subjecting themself to a years worth of toxic medications, but I don't know any more than anyone else, in fact probably a lot less.
Be well,
-- Jim
I know what to call it! Sides envy. I think that was how some of my posts were perceived, although I was just venting at the world in general.
Sides envy. Sounds like me coveting your curly fries.
Willow
Sorry to disagree, don't think your suffering from sfx envy :) The post mentioned went beyond simply reporting sfx from the get go and got into discussion of how balanced things are reported here, etc. I think you were just adding your perspective which was good.
Be well,
-- Jim
Willow
I have no argument with that. But I didn't dictate or suggest he extend treatment beyond what his assigned group was, I didn't in my previous posts to him nor have I in this thread. I merely found it odd he didn't voice any reservations or worries about it previously. It *is* possible to adhere to your preassigned group duration and yet still have, acknowledge and voice reservations/concerns regarding the historically abbreviated 24 week treatment cycle...especially when viewed within the context of the issues spelled out in my previous post. There is no logical paradox or contradiction in terms in doing so either. The so called "moral issue" concerning trial duration adherance does not negate/preclude/make inappropriate an open and honest discussion regarding the implications and plain facts surrounding an (historically) abbreviated geno-1 treatment cycle. Many, if not most people find these concepts "mutually exclusive". i.e. by simply even openly discussing them, then you are therefore by definition advocating non-adherence to your pre-assigned group: absolutely not true. The two concepts are not mutually exclusive, sorry.
Furthermore, the legitimacy of the so called "moral issue" surrounding group adherance is another topic that is absolutely debatable for a wide range of perfectly valid reasons (which have already been discussed, with no desire to revisit)...not the least of which is as you yourself stated: "Unless, of course, something happened during the trial -- such as a late response -- that wasn't anticipated and might suggest the shorter course would be too risky."
"Personally, I think this hypothetical person, given an RVR, stands a very good chance of SVR without subjecting themself to a years worth of toxic medications, but I don't know any more than anyone else, in fact probably a lot less."
That's just it, no one knows. And using the existing established statisical data that suggests SOC patients who RVR have significantly increased rates of SVR to extrapolate/forecast (likely) similar performance to a 24 week VX+SOC trial participant, is almost certainly comparing apples to oranges. The two situations are clearly different in very significant ways. The historical SOC (i.e. non VX) patients who achieved RVR and their subsequent SVR (even on truncated courses less than 48 wks), usually did/do so due to (1) favorable starting VL/fibrosis/age/BMI/etc criteria and/or (2) because they (or their virus) were particularly sensitive to IFN and/or ribavirin, and/or (3) because they happened to have a relatively weak/non-robust strain of HCV. And specifically in the case of those patients who are especially sensitive to SOC drugs, they derive the benefit of this high sensitivity throughout their entire treatment cycle (which is almost always for 48 weeks for geno 1, not 24 weeks as in apk's case). They experience an RVR because this sensitivity initially knocks the VL down rapidly, keeps the virus fully suppressed, and eventually permanently "eradicates" it (whatever that might mean)...all as an ongoing consequence of their high sensitivity to the IFN and/or riba alone. Obviously the reason for most EVR's in the case of the VX trial participants will not be because of this reason, but instead will be because of the addition of a direct acting antitviral drug (and again not solely because of a supertuned immune system occurring as a result of #2 above). In my view this is especially important because the VX dosing cycle only lasts for 12 weeks (with viable virus probably still present in the body at that point), the latter dosing period (be it 12 or 36 more weeks) will have the patient flying solo on SOC alone. And unless you happened to be one of the fortunate few who would have EVR-ed anyway without the the help of a PI (quite statisically unlikely considering apk's particular starting criteria), then that patient's SOC stimulated immune response will almost certainly not be as "hostile" to the remaining virus as it would be for an SOC EVR/SVR patient.
As a further hypothetical/speculative aside, there are even some who postulate that an SVR's virus is merely being continually held in check by an immune system that was "trained/tuned" during their treatment cycle. Not that I buy into that opinion, but it is a possibility that must be considered on some level, especially in lieu of the recent findings suggesting low level viral persistence in long term SVR patients. And if this scenario does have at least some validity to it, then adding VX into the mix and halving the treatment cycle may not necessarily achieve the same immune system "training" effect.
I carefully tried to avoid the "moral" issue this time around and was simply stating that 24 or 48 (or even 12) weeks should come as no surprise to anyone enrolled in the study and that some pre-thought should have gone into this prior to starting, with one option being that a trial is not right for a particular patient, medicially and/or psychologically.
Not so sure that APK was avoiding the potential downsides of being in the 24-week group, as much as pumping himself up as many of us do after making a tx decision or having one made for oneself as in a trial. I know I psyched myself up at various junctures in treatment -- didn't want to hear boo from anyone at those times :) -- and it was a necessary tool for me to be able to get over certain humps. Or maybe, APK genuinely has an instinctual feel -- combined with non VX RVR studies -- that 24 weeks is the magic number. I happen to have that feeling myself, but I really can't speak for APK or anyone else.
As to our hypothetical patient and how he might do with let's say a shortened VX plus SOC versus SOC alone, etc -- and whether the predictive meaning of current RVR (or SVR figures for that matter) correlate with VX RVR figures -- all that and more is hopefully what we will soon find out in these trials.
All the best luck to you and the rest of the VX crew as some go on, and some wait on post treatment labs. Forgot what group you are in or even if you've been unblinded at this point.
Be well,
-- Jim
-----------------
Think you've covered most of the bases although the genetic factor is being bandied around. Whatever the mechanism, the vigor of the response itself seems to trump the "why" of the response, at least according to some doctors I respect. So given the response (RVR), and going back to your example (2), this benefit *has* been shown to translate into comparable SVR data with shorter than 48 weeks (specifically 24 weeks) in those with a vigorous viral response. The big question again is how will RVR with VX play out vis a vie RVR with SOC. Vertex, APK, myself and others seem to be putting stock that it will play out the same -- or possibly even better. But even if if played out incrementally worse, given what appears to be such a very high percentage of RVRs with VX, then their SVR figures could still be significantly better than SOC even if their RVRs didn't translate over as well. Only time will tell.
-- Jim
In an earlier thread, someone posted about a PCR at 2 weeks, which supports your summation, and also what my own doctor told me. If the VX950/IFN whammies the virus quick, well, a person can go on for 24 weeks, which is LONG enough for anyone to try IFN. The lasting effects, after tx is stopped, are new frontiers, docs are learning more and more about hyperstimulating the immune system for long periods of time.
Or do I need to get the PDR out again? Long live PCR's at 2 weeks and love live 24 weeks of tx.
Willow
--------
Yes, that is the hope. That the rapid viral response (RVR) that VX delivers will translate into a sustained viral response (SVR). How many weeks of SOC are necessary after the initial 12-week dosing of VX and SOC, is what the current trials will help determine. In Europe, they are trialing some Arms without ribavirin, and if the results prove positive, no doubt we will see VX being trialed without ribavirin here as well. There was some talk at one point about trialing without peg as well, but I doubt if we will hear much on that for some time, if any, unless/until other antivirals are developed and a viable antiviral "cocktail" approach emerges worth trialing, similar to how HIV has been approached.
Willows: The lasting effects, after tx is stopped, are new frontiers, docs are learning more and more about hyperstimulating the immune system for long periods of time.
-----------------------------------
I suppose they are but so far the lion's share of time/study/emphasis has been on achieving SVR, not what happens to folks after they achieve SVR. This leads to a whole other discussion.
http://www.hivandhepatitis.com/
http://www.hivandhepatitis.com/hep_c/hepc_news_svr.html
http://www.hivandhepatitis.com/hep_c/hepc_news.html
http://www.projectsinknowledge.com/ (free registration may be required)
http://www.clinicaloptions.com/Hepatitis.aspx (free registration required)
At clinical options site, link above, you might want to start with "Doc Eye for the Hep Guy" a video module on re-treatment protocols. Also, the Shiffman slide presentations are informative as well. Sometimes hard to navigate the site, so best use the "search" bar at the top and enter key words such as "doc eye ofr the hep guy", "shiffman", etc.
My VL at first screening was 20,600,000. At second screening it was 27,500,000. Immediately before the first dose of treatment, it was 28,600,000. It was below 30IU/ml after 14 days of TX, and UND from there on. I believe that this is a strong predictor of SVR after 24 weeks. Your mileage may vary.
For once you're right, my mileage may vary. ;-)
In the meantime, here's to our respective SVR's. I really hope we all make it, one way or another.
"Kinder" can be interpreted as one likes, but to me part of that equation is how long one is exposed to interferon, which many, including myself think may cause long-term, possibly permanent problems because of what it does to the immune system. As to how "harsh" VX-950 was, we're still waiting for complete data to flow in on that score. Hopefully, the skin problems some here have reported will be addressed in future trials as they seem to have a bead on exactly what day they began. But regardless, unless it turns out that the skin issues were significantly more severe and common than so far described, I'd personally take 24 over 48 weeks anyway. As bad as some of my sides were prior to 24 weeks -- and I did have my worst sides then with the anemia -- it was the grinding down of my body, mind and soul from week 24-54 that really put me in the treatment gutter. So, yes, I think 24 weeks is kinder even if parts of it are not. Hope you had a happy New Years.
-- Jim
-- Jim
I guess it depends on how hard the tx hits a person, for me, most of the sides came and went, except for the mental exhaustion of not feeling well, and that one was not unkind in the true sense of the word. So for some, the new tx might seem kinder and gentler while for a large number, it might not, since most of the sides in SOC do not remain the full 48 wks, to our relief, they do ease off and most of the time they leave. Perhaps the fact that your skin condition made you suffer the whole time plays a big role in your description and hopes for the new tx. Good thing hemorrhoids did not flare as well.
I have a family member who suffered through an anal fissure and its repair and, well, I guess you can relate to his suffering better than I.
One nice long term effect from tx is that I am forgetting more and more how I felt then.
btw, I finally did get a cold, but still not a normal type since I only blew my nose twice in the few days it lasted. No nasal congestion per sae, or cough, just a mild throat soreness and hoarseness. I call it a cold because I did blow my nose a couple of times and got hoarse, but it still was not my old type of cold. I wonder if this virus was stronger than the others or if the immune system modification eventually wears off.
anything new has happened? any food fights I should know about? besides the booze threads...
be well
Ah, yes, the "booze" threads. As you mentioned, some things never change and I've limited myself either to not post, or simply post the facts as I know them and then leave the room.
I do agree that a significant part of our take on all this relates to our personal treatment experience, which puts us both at an advantage and disadvantage (at the same time) vis a vie the medical "experts" if you know what I mean.
And while my sfx may have been a bit harder than most, from what you've posted, I'd say yours were on the milder side. Maybe the "average tx experience", if there is such a thing, falls somewhere inbetween what we respectively experienced.
As to your family member with the anal fissure and repair. Whatever he said he was going through, it really was that bad.
All the best in the New Years and good luck with the little finches(?) you've adopted.
-- Jim